Skip to main content

Peer Review reports

From: Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling

Original Submission
9 Feb 2022 Submitted Original manuscript
21 Feb 2022 Reviewed Reviewer Report
21 Feb 2022 Reviewed Reviewer Report - Edith Hochhäuser
22 Feb 2022 Reviewed Reviewer Report
21 May 2022 Author responded Author comments - Jung-Sun Kim
Resubmission - Version 2
21 May 2022 Submitted Manuscript version 2
29 May 2022 Reviewed Reviewer Report - Edith Hochhäuser
18 Jun 2022 Author responded Author comments - Jung-Sun Kim
Resubmission - Version 3
18 Jun 2022 Submitted Manuscript version 3
13 Jul 2022 Author responded Author comments - Seul-Gee Lee
Resubmission - Version 4
13 Jul 2022 Submitted Manuscript version 4
Publishing
14 Jul 2022 Editorially accepted
7 Sep 2022 Article published 10.1186/s12916-022-02485-z

You can find further information about peer review here.

Back to article page